On 2025-05-08, 10x Genomics (TXG) announced earnings per share of $-0.36 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.45.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.35 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-08 | 2025-03-31 | $-0.45 | $-0.36 |
2025-02-12 | 2024-12-31 | $-0.32 | $-0.40 |
2024-10-29 | 2024-09-30 | $-0.34 | $-0.30 |
2024-08-08 | 2024-06-30 | $-0.47 | $-0.32 |
2024-04-30 | 2024-03-31 | $-0.46 | $-0.50 |
2024-02-15 | 2023-12-31 | $-0.36 | $-0.41 |
2023-11-02 | 2023-09-30 | $-0.45 | $-0.51 |
2023-08-03 | 2023-06-30 | $-0.39 | $-0.53 |
2023-05-03 | 2023-03-31 | $-0.38 | $-0.44 |
2023-02-15 | 2022-12-31 | $-0.29 | $-0.15 |
2022-11-02 | 2022-09-30 | $-0.45 | $-0.37 |
2022-08-08 | 2022-06-30 | $-0.40 | $-0.57 |
2022-05-04 | 2022-03-31 | $-0.37 | $-0.38 |
2022-02-16 | 2021-12-31 | $-0.06 | $-0.16 |
2021-11-03 | 2021-09-30 | $-0.18 | $-0.15 |
2021-08-04 | 2021-06-30 | $-0.26 | $-0.10 |
2021-05-05 | 2021-03-31 | $-0.25 | $-0.11 |
2021-02-17 | 2020-12-31 | $-0.28 | $-0.08 |
2020-11-10 | 2020-09-30 | $-0.33 | $-0.33 |
2020-08-11 | 2020-06-30 | $-0.59 | $-0.41 |
2020-05-11 | 2020-03-31 | $-0.20 | $-0.22 |
2020-02-18 | 2019-12-31 | $-0.15 | $-0.07 |
2019-11-07 | 2019-09-30 | $-0.13 | $-0.33 |